<tbody id="bkv2y"></tbody>

  1. <rp id="bkv2y"></rp>
      1. <rp id="bkv2y"></rp>

        <th id="bkv2y"></th>
        <button id="bkv2y"><acronym id="bkv2y"></acronym></button><button id="bkv2y"></button>
        <th id="bkv2y"><p id="bkv2y"></p></th>
      2. <tbody id="bkv2y"><track id="bkv2y"></track></tbody><span id="bkv2y"><p id="bkv2y"></p></span>
        <dd id="bkv2y"><pre id="bkv2y"></pre></dd>

          1. AACR Annual Meeting 2024

            March 11, 2024

            GemPharmatech will be attending the American Association for Cancer Research (AACR) Annual Meeting at the San Diego Convention Center from April 5??-10??, 2024! We look forward to having you visit us at Booth #3153, talk to our experts about your drug development plans, and learn more about our advanced mouse models and one-stop services for your preclinical research programs.


            Meet with us at AACR

            GemPharmatech has the world’s largest collection of genetically engineered mouse models. Understanding which of the 23,000 models is right for your project needs can be a daunting task—that is why we are making ourselves available all throughout the meeting to speak about your research and how we can help. 

            MEET US

            Poster Schedule:

            Our 6 meeting posters include some of our most cutting-edge research. If you are unable to attend a session, you can also book a meeting here.

            Sunday, April 7, 2024

            1:30 PM - 5:00 PM | Section 4

            Development of a novel murine model, NCG-M/hIL15, for enhanced post-HSC transplantation immunoreconstruction

            Poster Board Number:22

            1:30 PM - 5:00 PM | Section 22

            Breaking through ADCs resistance:Constructing preclinical enhertu-induced resistant model

            Poster Board Number:4

            Monday, Apr 8, 2024

            1:30 PM - 5:00 PM | Section 10

            Development and application of the NCG-hIL2 mouse model: A humanized platform for enhanced NK cell evaluation in ADCC efficacy testing

            Poster Board Number:18

            Tuesday, April 9, 2024

            9:00 AM - 12:30 PM | Section 9

            Patient-derived xenograft (PDX) models with differential HER2 expression for preclinical evaluation of HER2-targeted therapies

            Poster Board Number:14

            9:00 AM - 12:30 PM | Section 9

            BALB/c-hIL12RB1/hIL12RB2: A robust model for preclinical research in human IL-12 therapy

            Poster Board Number:13

            1:30 PM - 5:00 PM | Section 4

            NeoMab: A novel platform for fully human therapeutic antibody development

            Poster Board Number:13

            SPEAK WITH US AT AACR →

            Next : BIO KOREA 2024 Previous:N/A
            天涯明月刀小说 公翁的粗大放进我的秘密小说